You are here: Home » Current Affairs » Coronavirus » News
Business Standard

PM to meet vaccine makers today to discuss next phase of rollout

The Department of Biotechnology (DBT) is likely to make a presentation

Narendra Modi | Coronavirus | Coronavirus Tests

IANS  |  New Delhi 

PM Narendra Modi

A day after announcing Covid vaccine for all above 18 years from May 1, Prime Minister will meet the vaccine manufacturers on Tuesday evening through video conferencing.

Representatives of top drug makers from India and abroad, including companies whose vaccines have been approved by the government will attend the meeting scheduled at 6 p.m.

The Department of Biotechnology (DBT) is likely to make a presentation and also coordinate with all the participants of the meeting.

It is learnt that Prime Minister Modi called the meeting to discuss a plan for the next phase of vaccination starting May 1 in which everyone above 18 years is allowed to take the jab.

Till now, Indian drug regulators have approved two vaccines, 'Covidshield' manufactured by Serum Institute in India (SII) and 'Covaxin' by Bharat Biotech, for use in the country.

Drug regulators also approved Russian's 'Sputnik V' as the third vaccine marketed in the country by Dr Reddy's Laboratories. Other vaccines manufactured by global giants are also expected to be allowed in the country.

On Monday during a meeting chaired by Prime Minister Modi, an important decision of allowing vaccination to everyone above the age of 18 from May 1 was taken. Prime Minister Modi had also held discussions with doctors and representatives of pharma companies in separate meetings.



Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, April 20 2021. 14:24 IST